{"brief_title": "Montelukast in Exercise-Induced Bronchospasm - 2003 (0476-270)", "brief_summary": "The purpose of this study is to determine the effect of an approved medication being studied in support of a new approach in the prevention of exercise-induced asthma (a worsening of asthma caused by exercise, also known as exercise-induced bronchospasm), in participants who have a history of worsening asthma after exercise.", "condition": ["Asthma, Exercise-Induced"], "intervention_type": ["Drug", "Drug"], "intervention_name": ["Comparator: Montelukast", "Comparator: Placebo"], "description": ["Montelukast 10 mg tablet administered orally as a single witnessed dose before exercise challenge", "Placebo tablet administered orally as a single witnessed dose before exercise challenge"], "arm_group_label": ["1", "2", "2", "1"], "criteria": "Inclusion Criteria: - Participants with mild-to-moderate asthma Exclusion Criteria: - Medical history of a lung disorder (other than asthma) or a recent upper respiratory tract infection", "gender": "All", "minimum_age": "15 Years", "maximum_age": "45 Years", "healthy_volunteers": "No", "mesh_term": ["Bronchial Spasm", "Asthma, Exercise-Induced", "Montelukast"], "id": "NCT00092131"}